Intermune

Quote
I read somewhere on hear that they had prepicked candidates and only called others to make it look like they talked to people. This is totally the case and they wasted my time for over an hour on the phone and told me that I was going to next round and suddenly the calls stopped. Poor example if this is how the company operates. Good luck to you all.
 












Anonymous said:
I think you have a VERY limited background on the disease of IPF. Yes for shareholders it will be important to win the battle for first line use but these patients will still regress and die. My point is that there will be no "winner or loser" when comparing esbriet and nintedanib. If the medical community decides that Esbriet is the first line option then Nintedanib will get 2nd line. Unless they die on Esbriet, all patients will regress and move on to 2nd line therapy. With a different MOA, eventually it may be decided that upfront combo therapy will be the best option. Given that IPF falls under orphan disease there's a good probability insurances will cover upfront combo use.

Let's stop with the name calling and keep this discussion thread interesting and relevant.
Click to expand...

Totally agree with this. But not combo, it will take sometime for a combo of any drug to be used in clinical practice. DP will dictate a move to the next therapy.
 












Anonymous said:
This will be as good as a job as management allows. This will be a slam dunk in ipf as ots obviously the only show on the market. Upper management will dictate how performance is measured. I would look closely at how the territories are carved out. Census will be the one of the biggest insicators of how the territories perform.
Click to expand...

I'm curious if you are referring to whether you have a large academic institution with an IPF KOL in the territory vs. community Pulms? This is a concern for me. Waiting to see the territory from the manager or recruiter. IMO, best if you have a high-level KOL for sure!
 






Anonymous said:
Great points. I was contacted a few months ago for internal position in S.F. Never interviewed for a few reasons.
1. BI's drug is going to be really good
2. I had heard, being cheap on equity. Again never IV'd but I do know somebody in company currently.
3. The sales targets are astronomical. Not sure if they think they are selling the 1st bottle of water or a drug. That really scared me off.
4. 100% they are for sale. The risk of being out of work for 6 mos. plus, if company sold,which is a definite possibility in pharma, is not in my risk tolerance right now.

I just thought the risk and lack of financial benefits far outweighed what I currently have. So yes, for me, the grass was not greener on the other side.
Click to expand...

Where did you get ahold of the astronomical sales targets? Just curious if they have been made public since you didn't IV. Did someone share these with you at the company?
 






















































Anonymous said:
A lot of people have to wait till the Dallas interviews are over to get offers. Dallas interviews are the week of August 4th
Click to expand...

Are you sure that's how Intermune's doing things? Seems strange to put everyone on hold for two weeks while they go through another round. Some candidates could take another offer.
 


















Anonymous said:
Strange. Not going to help the company who is trying to hire the best possible talent .
Click to expand...

If you were in the loop, you would understand the process. Working around summer vacations to make sure the best candidate gets hired makes sense. That means staggered interviewing in some territories. If your competition couldn't make it to Phoenix due to a conflict, rest assured they wil be in Dallas.
 


















Top Bottom
Back
Quote